Cargando…

The potential role of RNA N6-methyladenosine in primary Sjögren’s syndrome

OBJECTIVE: The pathogenesis of primary Sjögren’s syndrome (pSS) remains incompletely understood. The N6-methyladenosine (m6A) RNA modification, the most abundant internal transcript modification, has close associations with multiple diseases. This study aimed to investigate the role of m6A in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Qiufeng, Wu, Xunyao, Deng, Chuiwen, Zhao, Lidan, Peng, Linyi, Zhou, Jiaxin, Zhang, Wen, Zhao, Yan, Fei, Yunyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710536/ https://www.ncbi.nlm.nih.gov/pubmed/36465909 http://dx.doi.org/10.3389/fmed.2022.959388

Ejemplares similares

Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome
por: Xiao, Qiufeng, et al.
Publicado: (2023)

The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren’s syndrome
por: Peng, Yu, et al.
Publicado: (2022)

LncRNA and mRNA expression profile of peripheral blood mononuclear cells in primary Sjögren’s syndrome patients
por: Peng, Yu, et al.
Publicado: (2020)

A Glimpse Into the Microbiome of Sjögren’s Syndrome
por: Deng, Chuiwen, et al.
Publicado: (2022)

N(6)-Methyladenosine Regulator-Mediated RNA Methylation Is Involved in Primary Sjögren's Syndrome Immunoinfiltration
por: He, Fang, et al.
Publicado: (2022)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022)

Serum Clusterin and Complement Factor H May Be Biomarkers Differentiate Primary Sjögren's Syndrome With and Without Neuromyelitis Optica Spectrum Disorder
por: Qiao, Lin, et al.
Publicado: (2019)

Role of N(6)-Methyladenosine RNA Modification in Cardiovascular Disease
por: Song, Dandan, et al.
Publicado: (2021)

The role of N6-methyladenosine (m(6)A) in kidney diseases
por: You, Luling, et al.
Publicado: (2023)

The Prevalence and Clinical Relevance of the DFS Immunofluorescence Staining Pattern in a Large ANA-Positive Cohort
por: Deng, Chuiwen, et al.
Publicado: (2022)

Corrigendum: The prevalence and clinical relevance of the DFS immunofluorescence staining pattern in a large ANA-positive cohort
por: Deng, Chuiwen, et al.
Publicado: (2023)

Role of N(6)-methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)
por: Ye, Tong, et al.
Publicado: (2022)

Role of N6-methyladenosine Modification in Cardiac Remodeling
por: Choy, ManTing, et al.
Publicado: (2022)

Transcriptome and N6-Methyladenosine RNA Methylome Analyses in Aortic Dissection and Normal Human Aorta
por: Zhou, Xianwu, et al.
Publicado: (2021)

The emerging role of RNA N6-methyladenosine methylation in breast cancer
por: Zheng, Fangchao, et al.
Publicado: (2021)

Our views of dynamic N(6)-methyladenosine RNA methylation
por: Zhao, Boxuan Simen, et al.
Publicado: (2018)

N(6)-Methyladenosine Methylomic Landscape of Ureteral Deficiency in Reflux Uropathy and Obstructive Uropathy
por: Shi, Hua, et al.
Publicado: (2022)

Single-Cell Sequencing of Immune Cell Heterogeneity in IgG4-Related Disease
por: Wu, Xunyao, et al.
Publicado: (2022)

Regulation of Antiviral Immune Response by N(6)-Methyladenosine of mRNA
por: Zhao, Baoxin, et al.
Publicado: (2021)

Complement factor H attenuates TNF-α-induced inflammation by upregulating EIF3C in rheumatoid arthritis
por: Jia, Yimeng, et al.
Publicado: (2023)

Widespread occurrence of N(6)-methyladenosine in bacterial mRNA
por: Deng, Xin, et al.
Publicado: (2015)

N6-Methyladenosine Modification Participates in the Progression of Hepatitis B Virus-Related Liver Fibrosis by Regulating Immune Cell Infiltration
por: Zhao, Tong, et al.
Publicado: (2022)

Alteration of N6-Methyladenosine RNA Profiles in Cisplatin-Induced Acute Kidney Injury in Mice
por: Li, Can-Ming, et al.
Publicado: (2021)

Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

The emerging roles of N6-methyladenosine RNA methylation in human cancers
por: Shen, Huafei, et al.
Publicado: (2020)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer
por: Liang, Zhixian, et al.
Publicado: (2020)

Importance of N(6)-methyladenosine RNA modification in lung cancer (Review)
por: Wang, Yueyang, et al.
Publicado: (2021)

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
por: Xu, Xiaoxin, et al.
Publicado: (2023)

The roles and therapeutic implications of messenger RNA internal N (7)‐methylguanosine and N (6)‐methyladenosine modifications in chemoresistance
por: Zhao, Zhicong, et al.
Publicado: (2023)

RNA N(6)-methyladenosine modification in cancers: current status and perspectives
por: Deng, Xiaolan, et al.
Publicado: (2018)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Inducible and reversible RNA N(6)-methyladenosine editing
por: Shi, Huaxia, et al.
Publicado: (2022)

The role of RNA N(6)-methyladenosine methyltransferase in cancers
por: Huang, Jiali, et al.
Publicado: (2021)

The roles of RNA N(6)-methyladenosine in esophageal cancer
por: Teng, Chuan, et al.
Publicado: (2022)

The Role of METTL3-Mediated N6-Methyladenosine (m6A) of JPH2 mRNA in Cyclophosphamide-Induced Cardiotoxicity
por: Zhu, Min, et al.
Publicado: (2021)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase
por: Ping, Xiao-Li, et al.
Publicado: (2014)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dorfual1hc4sp67sbl5gph0m43